NYSE:DOC - New York Stock Exchange, Inc. - US42250P1030 - REIT - Currency: USD
HEALTHPEAK PROPERTIES INC
NYSE:DOC (1/24/2025, 8:04:00 PM)
After market: 20.657 -0.17 (-0.83%)20.83
+0.18 (+0.87%)
The current stock price of DOC is 20.83 USD. In the past month the price increased by 3.22%. In the past year, price increased by 62.1%.
Adobe upgraded, Lam Research downgraded: Wall Street's top analyst calls
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL | WELLTOWER INC | 89.97 | 85.15B | ||
VTR | VENTAS INC | N/A | 25.51B | ||
ARE | ALEXANDRIA REAL ESTATE EQUIT | 61.97 | 17.76B | ||
OHI | OMEGA HEALTHCARE INVESTORS | 27.35 | 10.04B | ||
HR | HEALTHCARE REALTY TRUST INC | N/A | 5.95B | ||
CTRE | CARETRUST REIT INC | 37.38 | 5.03B | ||
AHR | AMERICAN HEALTHCARE REIT INC | N/A | 4.42B | ||
SBRA | SABRA HEALTH CARE REIT INC | 41.27 | 4.00B | ||
DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 3.90B | ||
DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 3.57B | ||
NHI | NATL HEALTH INVESTORS INC | 23.92 | 3.16B | ||
MPW | MEDICAL PROPERTIES TRUST INC | N/A | 2.82B |
Healthpeak Properties, Inc. is a Standard & Poor’s 500 company, which engages in acquiring, developing, owning, leasing, and managing healthcare real estate across the United States. The company is headquartered in Denver, Colorado and currently employs 193 full-time employees. The firm acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in and manage real estate focused on healthcare discovery and delivery. The company has a diversified portfolio of high-quality healthcare properties across three core asset classes of lab, outpatient medical, and continuing care retirement community (CCRC) real estate. The Company’s segments include Lab, Outpatient medical and CCRC. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Outpatient Medical segment includes outpatient medical buildings and hospitals. Outpatient medical buildings typically contain physicians’ offices and examination rooms.
HEALTHPEAK PROPERTIES INC
4600 South Syracuse Street, Suite 500
Denver COLORADO 53202 US
CEO: John T. Thomas
Employees: 193
Company Website: https://www.healthpeak.com/
Investor Relations: https://ir.healthpeak.com/
Phone: 19494070700
The current stock price of DOC is 20.83 USD.
The exchange symbol of HEALTHPEAK PROPERTIES INC is DOC and it is listed on the New York Stock Exchange, Inc. exchange.
DOC stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for DOC, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of DOC.
DOC has a dividend yield of 5.81%. The yearly dividend amount is currently 1.2.
DOC will report earnings on 2025-02-06, after the market close.
The PE ratio for DOC is 44.32. This is based on the reported non-GAAP earnings per share of 0.47 and the current share price of 20.83 USD.
The outstanding short interest for DOC is 1.59% of its float.
ChartMill assigns a technical rating of 5 / 10 to DOC. When comparing the yearly performance of all stocks, DOC is one of the better performing stocks in the market, outperforming 85.56% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to DOC. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months DOC reported a non-GAAP Earnings per Share(EPS) of 0.47. The EPS increased by 6.82% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 12.08% | ||
ROA | 1.55% | ||
ROE | 3.61% | ||
Debt/Equity | 1 |
ChartMill assigns a Buy % Consensus number of 80% to DOC. The Buy consensus is the average rating of analysts ratings from 24 analysts.
For the next year, analysts expect an EPS growth of -31.69% and a revenue growth 23.17% for DOC